The impact of cancer therapy on cognition in the elderly

Frontiers in Pharmacology

Volumn 4 APR, Issue , 2013, Pages

  Mandilaras, Victoria ^a,b   Wan Chow Wah, Doreen ^a,c,d   Monette, Johanne ^a,c,d   Gaba, Francine ^a,c,d   Monette, Michèle ^d   Alfonso, Linda ^a,c  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

Cancer; Chemobrain; Chemotherapy; Cognition; Elderly; Geriatric oncology

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; EXEMESTANE; FLUOROURACIL; GEMCITABINE; METHOTREXATE; PACLITAXEL;

ADJUVANT THERAPY; AGED; AGING; ARTICLE; BREAST CANCER; CANADA; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER THERAPY; CASE REPORT; COGNITIVE DEFECT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MALE; MEMORY DISORDER; PARTIAL MASTECTOMY; PROSPECTIVE STUDY; THORAX RADIOGRAPHY; UNSPECIFIED SIDE EFFECT;

EID: 84881489335     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2013.00048     Document Type: Article

References (27)

1. Ahles, T. A., and Saykin, A. J. (2007). Candidate mechanisms for chemotherapy-induced cognitive changes. Nat. Rev. Cancer 7, 192-201.
2. Alzheimer Society of Canada: "A new way of looking at the impact of dementia in Canada", alzheimer. ca, last modified September 26, 2012. Available at: http://www.alzheimer.ca/en/Get-involved/Raise-your-voice/A-new-way-of-looking-at-dementia
3. American Geriatrics Society 2012 Beers Criteria Update Expert Panel. (2012). American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J. Am. Geriatr. Soc. 60, 616-631.
4. Canadian Cancer Society's Steering Committee on Cancer Statistics. (2012). Canadian Cancer Statistics 2012. Canadian Cancer Society, Toronto.
5. Du, X. L., Xia, R., and Hardy, D. (2010). Relationship between chemotherapy use and cognitive impairments in older women with breast cancer: findings from a large population-based cohort. Am. J. Clin. Oncol. 33, 533-543.
6. Falleti, M. G., Sanfilippo, A., Maruff, P., Weih, L., and Phillips, K. A. (2005). The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature. Brain Cogn. 59, 60-70.
7. Folstein, M. F., Folstein, S. E., and Mchugh, P. R. (1975). "Mini-mental state". A practical method for grading the cognitive state of patients for clinicians. J. Psychiatr. Res. 12, 189-198.
8. Hede, K. (2008). Chemobrain is real but may need a new name. J. Natl. Cancer Inst. 100, 162-169.
9. Hermelink, K., Untch, M., Lux, M. P., Kreienberg, R., Beck, T., Bauerfeind, I., et al. (2007). Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study. Cancer 109, 1905-1913.
10. Hess, L. M., Chambers, S. K., Hatch, K., Hallum, A., Janicek, M. F., Buscema, J., et al. (2010). Pilot study of the prospective identification of changes in cognitive function during chemotherapy treatment for advanced ovarian cancer. J. Support. Oncol. 8, 252-258.
11. Hurria, A., Rosen, C., Hudis, C., Zuckerman, E., Panageas, K. S., Lachs, M. S., et al. (2006). Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study. J. Am. Geriatr. Soc. 54, 925-931.
12. Jansen, C. E., Cooper, B. A., Dodd, M. J., and Miaskowski, C. A. (2011). A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients. Support. Care Cancer 19, 1647-1656.
13. Koppelmans, V., Breteler, M. M., Boogerd, W., Seynaeve, C., Gundy, C., and Schagen, S. B. (2012). Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy. J. Clin. Oncol. 30, 1080-1086.
14. Kvale, E. A., Clay, O. J., Ross-Meadows, L. A., Mcgee, J. S., Edwards, J. D., Unverzagt, F. W., et al. (2010). Cognitive speed of processing and functional declines in older cancer survivors: an analysis of data from the ACTIVE trial. Eur. J. Cancer Care (Engl) 19, 110-117.
15. Mehlsen, M., Pedersen, A. D., Jensen, A. B., and Zachariae, R. (2009). No indications of cognitive side-effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy. Psychooncology 18, 248-257.
16. Minisini, A. M., De Faccio, S., Ermacora, P., Andreetta, C., Fantinel, R., Balestrieri, M., et al. (2008). Cognitive functions and elderly cancer patients receiving anticancer treatment: a prospective study. Crit. Rev. Oncol. Hematol. 67, 71-79.
17. Nasreddine, Z. S., Phillips, N. A., Bédirian, V., Charbonneau, S., Whitehead, V., Collin, I., et al. (2005). The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J. Am. Geriatr. Soc. 53, 695-699.
18. Quesnel, C., Savard, J., and Ivers, H. (2008). Cognitive impairments associated with breast cancer treatments: results from a longitudinal study. Breast Cancer Res. Treat. 116, 129-130.
19. Ruzich, M., Ryan, B., Owen, C., Delahunty, A., and Stuart-Harris, R. (2007). Prospective evaluation of cognitive function in patients with early breast cancer receiving adjuvant chemotherapy. Asia Pac. J. Clin. Oncol. 3, 125-133.
20. Schilder, C. M., Seynaeve, C., Linn, S. C., Boogerd, W., Beex, L. V., Gundy, C. M., et al. (2010). Cognitive functioning of postmenopausal breast cancer patients before adjuvant systemic therapy, and its association with medical and psychological factors. Crit. Rev. Oncol. Hematol. 76, 133-141.
21. Smith, B. D., Smith, G. L., Hurria, A., Hortobagyi, G. N., and Buchholz, T. A. (2009). Future of cancer incidence in the United States: burdens upon an aging, changing nation. J. Clin. Oncol. 27, 2758-2765.
22. Stewart, A., Bielajew, C., Collins, B., Parkinson, M., and Tomiak, E. (2006). A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer. Clin. Neuropsychol. 20, 76-89.
23. Stewart, A., Collins, B., Mackenzie, J., Tomiak, E., Verma, S., and Bielajew, C. (2008). The cognitive effects of adjuvant chemotherapy in early stage breast cancer: a prospective study. Psychooncology 17, 122-130.
24. Wefel, J. S., Saleeba, A. K., Buzdar, A. U., and Meyers, C. A. (2010). Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer 116, 3348-3356.
25. Weis, J., Poppelreuter, M., and Bartsch, H. H. (2009). Cognitive deficits as long-term side-effects of adjuvant therapy in breast cancer patients: 'subjective' complaints and 'objective' neuropsychological test results. Psychooncology 18, 775-782.
26. Whitney, K. A., Lysaker, P. H., Steiner, A. R., Hook, J. N., Estes, D. D., and Hanna, N. H. (2008). Is "chemobrain" a transient state? A prospective pilot study among persons with non-small cell lung cancer. J. Support. Oncol. 6, 313-321.
27. Yamada, T. H., Denburg, N. L., Beglinger, L. J., and Schultz, S. K. (2010). Neuropsychological outcomes of older breast cancer survivors: cognitive features ten or more years after chemotherapy. J. Neuropsychiatry Clin. Neurosci. 22, 48-54.